Results of this cohort study suggest that for patients with multiple sclerosis, presenting with PIRA after a first demyelinating event was not uncommon and suggests an unfavorable long-term prognosis, especially if it occurs early in the disease course.
No takes yet. Share an insight, caveat, or question.
Tur et al. (2022) studied this question.